GLNLX
Price
$23.25
Change
-$0.25 (-1.06%)
Updated
Sep 20 closing price
RSLBX
Price
$59.16
Change
-$0.28 (-0.47%)
Updated
Sep 20 closing price
Ad is loading...

GLNLX vs RSLBX

Header iconGLNLX vs RSLBX Comparison
Open Charts GLNLX vs RSLBXBanner chart's image
MFS Global New Discovery R3
Price$23.25
Change-$0.25 (-1.06%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World R2
Price$59.16
Change-$0.28 (-0.47%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GLNLX vs RSLBX Comparison Chart
Loading...
VS
GLNLX vs. RSLBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLNLX is a StrongBuy and RSLBX is a Buy.

FUNDAMENTALS
Fundamentals
RSLBX has more cash in the bank: 76.8B vs. GLNLX (79.1M). RSLBX pays higher dividends than GLNLX: RSLBX (0.15) vs GLNLX (0.00). GLNLX was incepted earlier than RSLBX: GLNLX (13 years) vs RSLBX (22 years). GLNLX (29.00) and RSLBX (29.00) have comparable annual turnover. GLNLX has a lower initial minimum investment than RSLBX: GLNLX (0) vs RSLBX (250). RSLBX (18.86) and GLNLX (18.38) have marching annual gain over last year. GLNLX return over 5 years is better than : 21.22 vs. RSLBX (17.84).
GLNLXRSLBXGLNLX / RSLBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years22 years-
Gain YTD6.9465.379129%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets79.1M76.8B0%
Annual Yield % from dividends0.000.15-
Returns for 1 year18.3818.8697%
Returns for 3 years-14.11-25.3256%
Returns for 5 years21.2217.84119%
Returns for 10 years56.8928.30201%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEB3300.00118.68
+3.73%
Seaboard Corp
ORIC11.250.09
+0.81%
Oric Pharmaceuticals
FMST3.09-0.02
-0.57%
Foremost Lithium Resource & Technology Ltd
QIPT2.73-0.10
-3.53%
Quipt Home Medical Corp
GMAB25.53-0.95
-3.59%
Genmab A/S ADS